UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

A Review of Paclitaxel and Novel Formulations Including Those Suitable for Use in Dogs

Journal of veterinary internal medicine, 2015-07, Vol.29 (4), p.1006-1012

2015

Volltextzugriff (PDF)

Response evaluation criteria for peripheral nodal lymphoma in dogs (v1.0)-a veterinary cooperative oncology group (VCOG) consensus document

Veterinary & comparative oncology, 2010-03, Vol.8 (1), p.28-37

2010

Volltextzugriff (PDF)

Preliminary evidence for biologic activity of toceranib phosphate (Palladia®) in solid tumours

Veterinary & comparative oncology, 2012-09, Vol.10 (3), p.194-205

2012

Volltextzugriff (PDF)

Prospective evaluation of toceranib phosphate in metastatic canine osteosarcoma

Veterinary & comparative oncology, 2018-03, Vol.16 (1), p.E23-E29

2018

Volltextzugriff (PDF)

Response evaluation criteria for solid tumours in dogs (v1.0): a Veterinary Cooperative Oncology Group (VCOG) consensus document

Veterinary & comparative oncology, 2015-09, Vol.13 (3), p.176-183

2015

Volltextzugriff (PDF)

Spontaneously Occurring Tumors of Companion Animals as Models for Human Cancer

Cancer investigation, 2000, Vol.18 (8), p.781-792

2000

Volltextzugriff (PDF)

Safety evaluation of combination toceranib phosphate (Palladia®) and piroxicam in tumour‐bearing dogs (excluding mast cell tumours): a phase I dose‐finding study

Veterinary & comparative oncology, 2012-09, Vol.10 (3), p.184-193

2012

Volltextzugriff (PDF)

Safety evaluation of combination vinblastine and toceranib phosphate (Palladia®) in dogs: a phase I dose‐finding study

Veterinary & comparative oncology, 2012-09, Vol.10 (3), p.174-183

2012

Volltextzugriff (PDF)

Development of an allogeneic whole-cell tumor vaccine expressing xenogeneic gp100 and its implementation in a phase ii clinical trial in canine patients with malignant melanoma

Cancer Immunology, Immunotherapy, 2006-04, Vol.55 (4), p.433-442

2006

Volltextzugriff (PDF)

Phase II clinical evaluation of lomustine chemotherapy for feline vaccine‐associated sarcoma

Veterinary & comparative oncology, 2012-12, Vol.10 (4), p.283-291

2012

Volltextzugriff (PDF)

c‐Kit Mutation and Localization Status as Response Predictors in Mast Cell Tumors in Dogs Treated with Prednisone and Toceranib or Vinblastine

Journal of veterinary internal medicine, 2018-01, Vol.32 (1), p.394-405

2018

Volltextzugriff (PDF)

Efficacy of pyridoxine to ameliorate the cutaneous toxicity associated with doxorubicin containing pegylated (Stealth) liposomes: a randomized, double-blind clinical trial using a canine model

Clinical cancer research, 1998-06, Vol.4 (6), p.1567-1571

1998

Volltextzugriff (PDF)

Efficacy of Radiation Therapy for the Treatment of Sialocele in Dogs

Journal of veterinary internal medicine, 2018-01, Vol.32 (1), p.107-110

2018

Volltextzugriff (PDF)

Alternating Rabacfosadine/Doxorubicin: Efficacy and Tolerability in Naïve Canine Multicentric Lymphoma

Journal of veterinary internal medicine, 2017-05, Vol.31 (3), p.872-878

2017

Volltextzugriff (PDF)

Feline lymphoma (145 cases): proliferation indices, cluster of differentiation 3 immunoreactivity, and their association with prognosis in 90 cats

Journal of veterinary internal medicine, 1998-09, Vol.12 (5), p.349-354

1998

Volltextzugriff (PDF)

Development of Inhalational Agents for Oncologic Use

Journal of clinical oncology, 2001-03, Vol.19 (6), p.1839-1847

2001

Volltextzugriff (PDF)

Phase II Evaluation of VDC‐1101 in Canine Cutaneous T‐Cell Lymphoma

Journal of veterinary internal medicine, 2014-09, Vol.28 (5), p.1569-1574

2014

Volltextzugriff (PDF)

Outcome and prognostic factors following adjuvant prednisone/vinblastine chemotherapy for high-risk canine mast cell tumour: 61 cases

Journal of Veterinary Medical Science, 2006, Vol.68(6), pp.581-587

2006

Volltextzugriff (PDF)

Pulse‐Administered Toceranib Phosphate Plus Lomustine for Treatment of Unresectable Mast Cell Tumors in Dogs

Journal of veterinary internal medicine, 2015-07, Vol.29 (4), p.1098-1104

2015

Volltextzugriff (PDF)

Hypofractionated radiation therapy for the treatment of microscopic canine soft tissue sarcoma

Veterinary & comparative oncology, 2016-12, Vol.14 (4), p.e135-e145

2016

Volltextzugriff (PDF)

Safety evaluation of combination CCNU and continuous toceranib phosphate (Palladia®) in tumour‐bearing dogs: a phase I dose‐finding study

Veterinary & comparative oncology, 2016-06, Vol.14 (2), p.202-209

2016

Volltextzugriff (PDF)

Adjuvant Therapy for Melanoma in Dogs: Results of Randomized Clinical Trials Using Surgery, Liposome-encapsulated Muramyl Tripeptide, and Granulocyte Macrophage Colony-stimulating Factor

Clinical cancer research, 1999-12, Vol.5 (12), p.4249-4258

1999

Volltextzugriff (PDF)

Combination Chemotherapy with Continuous l-Asparaginase, Lomustine, and Prednisone for Relapsed Canine Lymphoma

Journal of veterinary internal medicine, 2009-09, Vol.23 (5), p.1058-1063

2009

Volltextzugriff (PDF)

Rabacfosadine for relapsed canine B‐cell lymphoma: Efficacy and adverse event profiles of 2 different doses

Veterinary & comparative oncology, 2018-03, Vol.16 (1), p.E76-E82

2018

Volltextzugriff (PDF)

Inhalation Chemotherapy for Macroscopic Primary or Metastatic Lung Tumors: Proof of Principle Using Dogs with Spontaneously Occurring Tumors as a Model

Clinical cancer research, 1999-09, Vol.5 (9), p.2653-2659

1999

Volltextzugriff (PDF)

1 – 25 von 479

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(434)
Mit Volltextzugriff
(380)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

A Review of Paclitaxel and Novel Formulations Including Those Suitable for Use in Dogs

Response evaluation criteria for peripheral nodal lymphoma in dogs (v1.0)-a veterinary cooperative oncology group (VCOG) consensus document

Preliminary evidence for biologic activity of toceranib phosphate (Palladia®) in solid tumours

Prospective evaluation of toceranib phosphate in metastatic canine osteosarcoma

Response evaluation criteria for solid tumours in dogs (v1.0): a Veterinary Cooperative Oncology Group (VCOG) consensus document

Spontaneously Occurring Tumors of Companion Animals as Models for Human Cancer

Safety evaluation of combination toceranib phosphate (Palladia®) and piroxicam in tumour‐bearing dogs (excluding mast cell tumours): a phase I dose‐finding study

Safety evaluation of combination vinblastine and toceranib phosphate (Palladia®) in dogs: a phase I dose‐finding study

Development of an allogeneic whole-cell tumor vaccine expressing xenogeneic gp100 and its implementation in a phase ii clinical trial in canine patients with malignant melanoma

Phase II clinical evaluation of lomustine chemotherapy for feline vaccine‐associated sarcoma

c‐Kit Mutation and Localization Status as Response Predictors in Mast Cell Tumors in Dogs Treated with Prednisone and Toceranib or Vinblastine

Efficacy of pyridoxine to ameliorate the cutaneous toxicity associated with doxorubicin containing pegylated (Stealth) liposomes: a randomized, double-blind clinical trial using a canine model

Efficacy of Radiation Therapy for the Treatment of Sialocele in Dogs

Alternating Rabacfosadine/Doxorubicin: Efficacy and Tolerability in Naïve Canine Multicentric Lymphoma

Feline lymphoma (145 cases): proliferation indices, cluster of differentiation 3 immunoreactivity, and their association with prognosis in 90 cats

Development of Inhalational Agents for Oncologic Use

Phase II Evaluation of VDC‐1101 in Canine Cutaneous T‐Cell Lymphoma

Outcome and prognostic factors following adjuvant prednisone/vinblastine chemotherapy for high-risk canine mast cell tumour: 61 cases

Pulse‐Administered Toceranib Phosphate Plus Lomustine for Treatment of Unresectable Mast Cell Tumors in Dogs

Hypofractionated radiation therapy for the treatment of microscopic canine soft tissue sarcoma

Safety evaluation of combination CCNU and continuous toceranib phosphate (Palladia®) in tumour‐bearing dogs: a phase I dose‐finding study

Adjuvant Therapy for Melanoma in Dogs: Results of Randomized Clinical Trials Using Surgery, Liposome-encapsulated Muramyl Tripeptide, and Granulocyte Macrophage Colony-stimulating Factor

Combination Chemotherapy with Continuous l-Asparaginase, Lomustine, and Prednisone for Relapsed Canine Lymphoma

Rabacfosadine for relapsed canine B‐cell lymphoma: Efficacy and adverse event profiles of 2 different doses

Inhalation Chemotherapy for Macroscopic Primary or Metastatic Lung Tumors: Proof of Principle Using Dogs with Spontaneously Occurring Tumors as a Model

Suchergebnisse filtern